Identification and characterization of stressed degradation products of prulifloxacin using LC–ESI-MS/Q-TOF, MSn experiments: Development of a validated specific stability-indicating LC

Identification and characterization of stressed degradation products of prulifloxacin using LC–ESI-MS/Q-TOF, MSn experiments: Development of a validated specific stability-indicating LC–MS method

Published:2011-11 Issue:3 Volume:56 Page:560-568
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Raju B.,Ramesh M.,Srinivas R.,Raju S. Satyanarayana,Venkateswarlu Y.

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference22 articles.

1. Stability testing of new drug substances and products Q1A (R2);ICH,2003

2. Draft Stability Testing of Active Pharmaceutical Ingredients and Pharmaceutical Products;WHO,2007

3. Note for Guidance on Stability Testing: Stability Testing of Existing Active Substances and Related Finished Products, Committee for Proprietary Medicinal Products;CPMP,2002

4. Guidance for Industry Stability Testing of Existing Drug Substances and Products, Therapeutic Products Directorate;TPD,2003

5. The importance and the challenges of impurity profiling in modern pharmaceutical analysis;Gorog;TrAC,2006

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Separation and characterization of degradation impurities of upadacitinib by liquid chromatography and high resolution mass spectrometry;Journal of Chromatography B;2024-09

2. Stress degradation study of Etoricoxib, isolation, and characterization of major degradation impurity by preparative high‐performance liquid chromatography, liquid chromatography‐mass spectrometry, and nuclear magnetic resonance: Validation of ultra‐performance liquid chromatography method;SEPARATION SCIENCE PLUS;2024-01-09

3. A study on structural characterization of potential impurities of Sugammadex sodium using LC/ESI/QTOF/MS/MS and NMR;Journal of Pharmaceutical and Biomedical Analysis;2022-01

4. Importance of LCMS in Forced Degradation Studies for new Chemical Entities;International Journal of pharma and Bio Sciences;2021-01-25

5. EVOLUÇÃO DA LEGISLAÇÃO E DAS TÉCNICAS ANALÍTICAS APLICADAS A ESTUDOS DE ESTABILIDADE DE INSUMOS E PRODUTOS FARMACÊUTICOS;Química Nova;2020